New Weight-Loss shot CPX101 shows promise in phase 2 trial
NCT ID NCT06532578
First seen Apr 17, 2026 · Last updated May 25, 2026 · Updated 7 times
Summary
This study tested a new drug called CPX101 to help people who are overweight or obese lose weight. The trial included 240 adults without diabetes who received either the drug or a placebo over 24 weeks. The main goal was to see how much weight they lost and if the drug was safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Paratus Clinical Research
Chatswood, New South Wales, Australia
Conditions
Explore the condition pages connected to this study.